Cite
HARVARD Citation
Cholujova, D. et al. (2017). Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma. British journal of haematology. pp. 756-771. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cholujova, D. et al. (2017). Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma. British journal of haematology. pp. 756-771. [Online].